Rachel Bender Ignacio, MD, MPH
University of Washington
Assistant Professor of Allergy and Infectious Diseases, Adjunct Assistant Professor of Epidemiology
Seattle, WA
Assistant Professor of Vaccine and Infectious Diseases
Fred Hutchinson Cancer Research Center
Seattle, WA
Constance A. Benson, MD
University of California San Diego
Professor of Medicine
San Diego, CA
Principal Investigator, UCSD HIV Collaborative Clinical Trials Unit
UCSD Antiviral Research Center
San Diego, CA
Dr Benson is Professor of Medicine, Senior Attending Physician in the Division of Infectious Diseases, Director of the Infectious Diseases Training Program, Director of the Antiviral Research Center, and the Principal Investigator of the CD4 Collaborative HIV Clinical Trials Unit at the University of California San Diego in San Diego, California, and President of the CROI Foundation. She is an internationally recognized researcher and clinician and has worked in the field of HIV/AIDS since 1984. Most recently her research has focused on the treatment and prevention of HIV-associated tuberculosis, the development of rapid point-of-care diagnostic assays for resource-limited settings, and new antiretroviral drug development.
(Updated July 18, 2024)
Debika Bhattacharya, MD, MS
University of California Los Angeles
Clinical Professor
Los Angeles, CA
David Geffen School of Medicine
Los Angeles, CA
Cheríe Blair, MD, PhD
University of California Los Angeles
Assistant Clinical Professor
Los Angeles, CA
Jill Blumenthal, MD, MAS
University of California San Diego
Associate Professor of Medicine
San Diego, CA
Paul L. Bollyky, MD
Stanford University
Professor of Immunology/Microbiology
Stanford, CA
Dr Bollyky (pronounced “boy-key”) is a Professor of Immunology/Microbiology and an Infectious Disease physician at Stanford University.
Dr Bollyky is originally from Stanford, Connecticut. He received his DPhil at the University of Oxford, and his MD at Harvard Medical School. He completed his residency training at Brigham and Women’s Hospital and his Fellowship Training in Infectious Diseases at the University of Washington. Paul joined the Stanford University Medical School faculty in 2013. He is currently Associate Division Chief of the Division of Infectious Diseases and Co-Director of the Stanford Infectious Diseases Fellowship Program.
At Stanford, his lab studies bacteriophages and bacterial infections. His team is interested in understanding how phages in the human body contribute to health and disease and in using bacteriophages to treat chronic skin and lung infections.
(Updated July 18, 2024)
Joseph Bondy-Denomy, PhD
University of California San Francisco
Professor, Department of Microbiology & Immunology
San Francisco, CA
Dr Bondy-Denomy is a Professor in the Department of Microbiology & Immunology at the University of California San Francisco (UCSF). Prior to coming to UCSF, Dr Bondy-Denomy was a PhD student with Alan Davidson at the University of Toronto and received his undergraduate degree in Biology from the University of Waterloo. His lab is focused on studying the interactions between bacteriophages and the defense systems encoded by host bacteria, specifically focused on the human pathogen Pseudomonas aeruginosa. Historically, the lab has studied clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems and their inhibitors, anti-CRISPR proteins. More recent work has broadened that interest to include unique mechanisms of CRISPR-Cas evasion, such as “phage nucleus” compartments. The lab has also begun to characterize the immunity and anti-immunity mechanisms of Gabija, cyclic-oligonucleotide-based anti-phage signaling system (CBASS), Thoeris, Shango, and Jumbo phage killer defenses. Work in the Bondy-Denomy lab has been funded by the National Institutes of Health (NIH), Defense Advanced Research Projects Agency (DARPA), the Searle Scholars Program, the Vallee Foundation, and the Innovative Genomics Institute. Dr Bondy-Denomy serves as a reviewer for the NIH and other granting agencies and for many journals. He is also the cofounder of Acrigen Biosciences, a gene editing company using anti-CRISPR proteins, and on the scientific advisory board of SNIPR Biome, Leapfrog Bio, and Excision Biotherapeutics.
(Updated July 18, 2024)
David R. Boulware MD, MPH
University of Minnesota
McKnight Distinguished Professor, Infectious Disease & International Medicine
Minneapolis, MN
